A carregar...
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
BACKGROUND: VeriStrat is a blood-based proteomic test with predictive and prognostic significance in second-line treatments for non-small cell lung cancer (NSCLC). This trial was designed to investigate the role of VeriStrat in first-line treatment of advanced NSCLC with standard chemotherapy. Here...
Na minha lista:
Publicado no: | Br J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5220151/ https://ncbi.nlm.nih.gov/pubmed/27898657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.387 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|